Denervation therapy shows potential for heart failure-related pulmonary hypertension

An open-label trial indicates that denervation may offer a promising treatment pathway for individuals with heart failure-related pulmonary hypertension. This initial finding is significant as it suggests a potential new therapeutic option for a serious condition, though further clinical confirmation is necessary.